We are excited to announce that OHDSI is performing another important COVID-19 study titled “Adverse Events of Special Interest within COVID-19 Subjects”. Extending on our previous work by Li et al. (1,2) that brought understanding to the incidence rates of adverse events of special interest (AESI) for COVID-19, this work will look at the rates of these AESIs in patients who had COVID-19 disease.
The protocol is available here:
Please note you are responsible for local information governance. This includes any arrangements regarding ethics and/or data access requirements.
We will be collecting results between, November 28, 2021 until January 1, 2022. In order to participate you need to email Erica Voss (evoss3 (at) its. jnj. com) who will provide you an appropriate data partner ID and provide the private key needed to load the results.
Many thanks to the Vaccine Evidence team that helped pull together this protocol and special thanks to @msuchard, @schuemie, @anthonysena, @Gowtham_Rao, and @Azza_Shoaibi who helped prepare and test the package.